Mar 11, 2021 / 07:25PM GMT
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst
Good afternoon. My name is Gena Wang. I'm SMid-Cap Biotech Analyst at the Barclays. Welcome to our second Virtual Global Healthcare Conference. First, I wish everyone stay healthy, and I would like to thank all the participants, investors and companies and especially our event team and our corporate access team who made this virtual healthcare conference possible. And with that, I would like to introduce our next presenter, John Evans from Beam. John, I hand over to you.
John M. Evans - Beam Therapeutics Inc. - CEO & Director
Great. Thank you, Gena, and hello, everybody. Great to be with you. So let me bring up some slides that I think will help us introduce the Beam story, and then we'll close that down and go into a Q&A, which I think will be hopefully quite illuminating.
So Beam is really a next generation of technology in gene editing. And the goal here is really to improve our ability to make precise changes in genes that could be potentially curative and do so without
Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers